Vascular Endothelial Growth Factor (VEGF) isoform expression and activity in human and murine lung injury

Respiratory Research

Volumn 10, Issue , 2009, Pages

  Medford, Andrew R L ^a   Douglas, Samantha K ^a   Godinho, Sofia I H ^a   Uppington, Kay M ^a   Armstrong, Lynne ^a   Gillespie, Kathleen M ^a   van Zyl, Berendine ^a   Tetley, Terry D ^b   Ibrahim, Nassif B N ^c   Millar, Ann B ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LIPOPOLYSACCHARIDE; MESSENGER RNA; RNA; SOLUBLE VASCULOTROPIN RECEPTOR 1; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 121; VASCULOTROPIN 165; VASCULOTROPIN 189; VASCULOTROPIN RECEPTOR 1; ISOPROTEIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS EPITHELIUM; LUNG PARENCHYMA; MACROPHAGE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SUPERNATANT; UPREGULATION; VASCULAR ENDOTHELIUM; AGED; ANIMAL; C57BL MOUSE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LUNG; LUNG INJURY; METABOLISM; SPECIES DIFFERENCE; TISSUE DISTRIBUTION;

AGED; ANIMALS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LUNG; LUNG INJURY; MALE; MICE; MICE, INBRED C57BL; PROTEIN ISOFORMS; SPECIES SPECIFICITY; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 66649086937     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-10-27     Document Type: Article

References (40)

1. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000, 342(18):1334-1349. 10.1056/NEJM200005043421806, 10793167.
2. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380(6573):435-439. 10.1038/380435a0, 8602241.
3. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003, 9:669-676. 10.1038/nm0603-669, 12778165.
4. Kaner RJ, Crystal RG. Compartmentalization of vascular endothelial growth factor to the epithelial surface of the human lung. Mol Med 2001, 7(4):240-246. 1950032, 11471568.
5. Koyama S, Sato E, Tsukadaira A, Haniuda M, Numanami H, Kurai M, Nagai S, Izumi T. Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro. Eur Respir J 2002, 20(6):1449-1456. 10.1183/09031936.02.00089802, 12503703.
6. Boussat S, Eddahibi S, Coste A, Fataccioli V, Gouge M, Housset B, Adnot S, Maitre B. Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 2000, 279(2):L371-L378.
7. Thickett DR, Armstrong L, Christie SJ, Millar AB. Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. Am J Respir Crit Care Med 2001, 164(9):1601-1605.
8. Thickett DR, Armstrong L, Millar AB. A role for vascular endothelial growth factor in acute and resolving lung injury. Am J Respir Crit Care Med 2002, 166(10):1332-1337. 10.1164/rccm.2105057, 12421742.
9. Maitre B, Boussat S, Jean D, Gouge M, Brochard L, Housset B, Adnot S, Delclaux C. Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury. Eur Respir J 2001, 18(1):100-106. 10.1183/09031936.01.00074701, 11510779.
10. Hanaoka M, Droma Y, Naramoto A, Honda T, Kobayashi T, Kubo K. Vascular endothelial growth factor in patients with high-altitude pulmonary edema. J Appl Physiol 2003, 94:1836-1840.
11. Abadie Y, Bregeon F, Papazian L, Lange F, Chailley-Heu B, Thomas P, Duvaldestin P, Adnot S, Maitre B, Delclaux C. Decreased VEGF concentration in lung tissue and vascular injury during ARDS. Eur Respir J 2005, 25(1):139-146. 10.1183/09031936.04.00065504, 15640335.
12. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991, 266(18):11947-11954.
13. Robinson CJ, Stringer SE. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci 2001, 114(Pt 5):853-865.
14. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991, 5(12):1806-1814. 10.1210/mend-5-12-1806, 1791831.
15. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004, 25(4):581-611. 10.1210/er.2003-0027, 15294883.
16. Fehrenbach H. Alveolar epithelial type II cell: defender of the alveolus revisited. Respir Res 2001, 2(1):33-46. 59567, 11686863, 10.1186/rr36.
17. Maniscalco WM, Watkins RH, Finkelstein JN, Campbell MH. Vascular endothelial growth factor mRNA increases in alveolar epithelial cells during recovery from oxygen injury. Am J Respir Cell Mol Biol 1995, 13(4):377-386.
18. Brown KR, England KM, Goss KL, Snyder JM, Acarregui MJ. VEGF induces airway epithelial cell proliferation in human fetal lung in vitro. Am J Physiol Lung Cell Mol Physiol 2001, 281(4):L1001-L1010.
19. Roberts JR, Perkins GD, Fujisawa T, Pettigrew KA, Gao F, Ahmed A, Thickett DR. Vascular endothelial growth factor promotes physical wound repair and is anti-apoptotic in primary distal lung epithelial and A549 cells. Crit Care Med 2007, 35(9):2164-2170. 10.1097/01.CCM.0000281451.73202.F6, 17855831.
20. Raoul W, Chailley-Heu B, Barlier-Mur AM, Delacourt C, Maitre B, Bourbon JR. Effects of vascular endothelial growth factor (VEGF) on isolated fetal alveolar type II cells. Am J Physiol Lung Cell Mol Physiol 2004, 286(6):L1293-L1301. 10.1152/ajplung.00157.2003, 14742307.
21. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall JR, Morris A, Spragg R. Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee. Intensive Care Med 1994, 20(3):225-232. 10.1007/BF01704707, 8014293.
22. Krafft AE, Duncan BW, Bijwaard KE, Taubenberger JK, Lichy JH. Optimization of the Isolation and Amplification of RNA From Formalin-fixed, Paraffin-embedded Tissue: The Armed Forces Institute of Pathology Experience and Literature Review. Mol Diagn 1997, 2(3):217-230. 10.1016/S1084-8592(97)80032-X, 10462613.
23. Godinho SIMA. An animal model of the acute respiratory distress syndrome (ARDS). European Respiratory Journal 2002, 20:486s.
24. Witherden IR, Tetley TD, Rogers DF, Donnelly LE. Isolation and culture of human alveolar type II pneumocytes. Methods in Molecular Medicine, Volume 56 (book) 2001, Chapter 11:137-146. Human airway inflammation; sampling techniques and analytical protocols: Humana Press Inc., Totawa, New Jersey.
25. Zhao D, Zhu BL, Ishikawa T, Quan L, Li DR, Maeda H. Real-time RT-PCR quantitative assays and postmortem degradation profiles of erythropoietin, vascular endothelial growth factor and hypoxia-inducible factor 1 alpha mRNA transcripts in forensic autopsy materials. Legal medicine (Tokyo, Japan) 2006, 8(2):132-136.
26. Koyama S, Sato E, Haniuda M, Numanami H, Nagai S, Izumi T. Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis. Am J Respir Crit Care Med 2002, 166(3):382-385. 10.1164/rccm.2103112, 12153975.
27. Lieto E, Ferraraccio F, Orditura M, Castellano P, Mura AL, Pinto M, Zamboli A, De Vita F, Galizia G. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients. Annals of Surgical Oncology 2008, 15(1):69-79. 10.1245/s10434-007-9596-0, 17896140.
28. Mura M, Dos Santos CC, Stewart D, Liu M. Vascular endothelial growth factor and related molecules in acute lung injury. J Appl Physiol 2004, 97(5):1605-1617. 10.1152/japplphysiol.00202.2004, 15475552.
29. Mura M, Han B, Andrade CF, Seth R, Hwang D, Waddell TK, Keshavjee S, Liu M. The early responses of VEGF and its receptors during acute lung injury: implication of VEGF in alveolar epithelial cell survival. Critical care (London, England) 2006, 10(5):R130. 1751039, 16968555.
30. Perkins GD, Roberts J, McAuley DF, Armstrong L, Millar A, Gao F, Thickett DR. Regulation of vascular endothelial growth factor bioactivity in patients with acute lung injury. Thorax 2005, 60(2):153-158. 1747283, 15681505, 10.1136/thx.2004.027912.
31. Shraga-Heled N, Kessler O, Prahst C, Kroll J, Augustin H, Neufeld G. Neuropilin-1 and neuropilin-2 enhance VEGF121 stimulated signal transduction by the VEGFR-2 receptor. Faseb J 2007, 21(3):915-926. 10.1096/fj.06-6277com, 17185751.
32. Montgomery AB, Stager MA, Carrico CJ, Hudson LD. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985, 132(3):485-489.
33. Medford AR, Millar AB. Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?. Thorax 2006, 61(7):621-626. 1828639, 16807391, 10.1136/thx.2005.040204.
34. Berse B, Brown LF, Van de WL, Dvorak HF, Senger DR. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992, 3(2):211-220. 275520, 1550962.
35. Corne J, Chupp G, Lee CG, Homer RJ, Zhu Z, Chen Q, Ma B, Du Y, Roux F, McArdle J, Waxman AB, Elias JA. IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J Clin Invest 2000, 106(6):783-791. 381393, 10995789, 10.1172/JCI9674.
36. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, Plaisance S, Dor Y, Keshet E, Lupu F, Nemery B, Dewerchin M, Van Veldhoven P, Plate K, Moons L, Collen D, Carmeliet P. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 2002, 8(7):702-710.
37. Karmpaliotis D, Kosmidou I, Ingenito EP, Hong K, Malhotra A, Sunday ME, Haley KJ. Angiogenic growth factors in the pathophysiology of a murine model of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2002, 283(3):L585-L595.
38. Watkins RH, D'Angio CT, Ryan RM, Patel A, Maniscalco WM. Differential expression of VEGF mRNA splice variants in newborn and adult hyperoxic lung injury. Am J Physiol 1999, 276(5 Pt 1):L858-L867.
39. Berthiaume Y, Lesur O, Dagenais A. Treatment of adult respiratory distress syndrome: plea for rescue therapy of the alveolar epithelium. Thorax 1999, 54(2):150-160. 1745424, 10325922.
40. Ohwada A, Yoshioka Y, Iwabuchi K, Nagaoka I, Dambara T, Fukuchi Y. VEGF regulates the proliferation of acid-exposed alveolar lining epithelial cells. Thorax 2003, 58(4):328-332. 1746622, 12668796, 10.1136/thorax.58.4.328.